Rare disease

Vasculitis

Clinical trials recruiting in Australia for Vasculitis, a rare disease, as the public registries list them.

Also called: Systemic vasculitis; Angiitis

Sources: ClinicalTrials.gov, MedlinePlus, Orphanet Checked: 11 October 2026 Not medical advice

At a glance

6 trials recruiting in Australia

245 trials recruiting overseas

1-9 / 100 000 (Point prevalence, Europe, Not yet validated) prevalence

Not recorded age of onset

11 October 2026 date last checked

Trials in Australia

This Australian count is likely to be on the low side. It counts the trials this site files under this condition; the registry’s own search is broader and also returns closely related conditions, some of which have their own page here. If you are searching widely, check the registry as well — every trial below links to its own record.

  • Recruiting Not a phased study

    Study for people with Vasculitis

    Where
    • Online Patient Enrollment System, Sydney — Recruiting
    Who can join Age child, adult, older adult. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Sanford Health
    Timeline
    Started 1 July 2010 Today 16 October 2026 Estimated completion 1 December 2100

    NCT01793168 · Checked 11 October 2026

  • Recruiting Not a phased study

    Study for people with Vasculitis

    Where
    • Flinders University, Adelaide — Recruiting
    • University of Adelaide, Adelaide — Recruiting
    Who can join Age child, adult, older adult. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor University of Siena
    Timeline
    Started 6 August 2020 Today 16 October 2026 Estimated completion 6 August 2026

    Past estimated completion. The registry still lists this trial as open, and the date it gave for finishing has been and gone. Confirm with the official record before you act on it.

    NCT05200715 · Checked 11 October 2026

  • Recruiting Phase 1

    Phase 1 study for people with Vasculitis

    Where
    • Royal Prince Alfred Hospital, Camperdown (NSW) — Recruiting
    • Westmead Hospital, Sydney (NSW) — Recruiting
    • Campbelltown Public Hospital, Sydney (NSW) — Recruiting
    • The Alfred Hospital, Melbourne (VIC) — Recruiting
    • Box Hill Hospital, Melbourne (VIC) — Recruiting
    Who can join Age 18 Years to 85 Years. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Chugai Pharmaceutical
    Timeline
    Started 19 August 2024 Today 16 October 2026 Estimated completion 31 March 2027

    NCT06371417 · Checked 11 October 2026

  • By invitation Phase 1

    Phase 1 study for people with Vasculitis

    Where

    No Australian site on this record is listed as recruiting right now, even though the trial itself is open. Check with the site or the official record before travelling.

    • Royal Prince Alfred Hospital, Camperdown (NSW) — this site's status is not stated on the record
    • Westmead Hospital, Sydney (NSW) — this site's status is not stated on the record
    • Campbelltown Public Hospital, Sydney (NSW) — this site's status is not stated on the record
    • The Alfred Hospital, Melbourne (VIC) — this site's status is not stated on the record
    • Box Hill Hospital, Melbourne (VIC) — this site's status is not stated on the record
    Who can join Age 18 Years to 85 Years. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Chugai Pharmaceutical
    Timeline
    Started 9 December 2024 Today 16 October 2026 Estimated completion 28 February 2028

    NCT06723106 · Checked 11 October 2026

  • Recruiting Phase 2

    Phase 2 study for people with Vasculitis

    Where
    • Nkarta Investigational Site, Melbourne (VIC) — Recruiting
    Who can join Age 18 Years to 75 Years. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Nkarta, Inc.
    Timeline
    Started 4 November 2024 Today 16 October 2026 Estimated completion 1 October 2028

    NCT06733935 · Checked 11 October 2026

  • Recruiting Phase 2

    Phase 2 study for people with Vasculitis

    Where
    • Research Site, Clayton (VIC) — Recruiting
    • Research Site, Heidelberg (VIC) — Recruiting
    • Research Site, Nedlands (WA) — Recruiting
    • Research Site, Wollongong (NSW) — Recruiting
    Who can join Age 18 Years to 80 Years. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Alexion Pharmaceuticals, Inc.
    Timeline
    Started 26 November 2025 Today 16 October 2026 Estimated completion 11 October 2027

    NCT07160608 · Checked 11 October 2026

Trials overseas

245 trials for this disease are open to new participants outside Australia, as ClinicalTrials.gov listed them on 11 October 2026. Voxsanity does not publish a page for any of them; the searches below reach them at the registry.

These overseas counts are likely too high. They come from the registry’s own search, which expands a condition name to related conditions, so some of the trials counted are for a different disease in the same family.

Trials not shown here

Some Australian trials are registered only on the Australian New Zealand Clinical Trials Registry and are not shown here. Search them at Australian Clinical Trials.

Key facts

Inheritance Not recorded
Genes Not recorded
Prevalence 1-9 / 100 000 (Point prevalence, Europe, Not yet validated)
Age of onset Not recorded

Orphadata Science: Free access data from Orphanet. © INSERM 1999. Available on https://www.orphadata.com. Used under CC BY 4.0. Source: Orphanet / Orphadata (orphadata.com).

About Vasculitis

The text below is reproduced exactly as its source published it. It has not been edited, shortened or rewritten.

Vasculitis is an inflammation of the blood vessels. It happens when the body's immune system attacks the blood vessel by mistake. It can happen because of an infection, a medicine, or another disease. The cause is often unknown. Vasculitis can affect arteries, veins and capillaries. Arteries are vessels that carry blood from the heart to the body's organs. Veins are the vessels that carry blood back to the heart. Capillaries are tiny blood vessels that connect the small arteries and veins. When a blood vessel becomes inflamed, it can: - Narrow, making it more difficult for blood to get through. - Close off completely so that blood can't get through. - Stretch and weaken so much that it bulges. The bulge is called an aneurysm. If it bursts, it can cause dangerous bleeding inside the body. Symptoms of vasculitis can vary, but usually include fever, swelling and a general sense of feeling ill. The main goal of treatment is to stop the inflammation. Steroids and other medicines to stop inflammation are often helpful. NIH: National Heart, Lung, and Blood Institute

US source; availability in Australia may differ.

Source: MedlinePlus Health Topics (medlineplus.gov), public domain (U.S. National Library of Medicine). Read the full source.

Sources and dates

  • ClinicalTrials.gov – trial records, statuses and site lists
  • MedlinePlus – the About text above, reproduced exactly
  • Orphanet / Orphadata – prevalence, age of onset, inheritance, genes and alternative names, used under CC BY 4.0
  • ClinicalTrials.gov processing date: 7 August 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Orphanet citation

Orphadata Science: Free access data from Orphanet. © INSERM 1999. Available on https://www.orphadata.com. Used under CC BY 4.0. Source: Orphanet / Orphadata (orphadata.com). Accessed 20 September 2026.

ORPHA:52759

Tell us which conditions matter to you

We use requests to help decide what to add next. Telling us about a condition is not a promise that we will add it, and we cannot say when any condition might appear.